Bumble’s $1.3B Buyout, Alaunos’ $350M Funding, JPMorgan’s $15.3B Profit Drive Mixed Stock Moves

Mumbai, 13 October 2026: US stock markets saw a busy corporate news session on October 13, 2026, as companies across technology, banking, healthcare, consumer goods and energy announced earnings, acquisitions, financing plans and dividend decisions. Bumble’s proposed $1.3 billion acquisition, major funding announcements from AI infrastructure companies and quarterly results from leading banks and healthcare firms attracted investor attention. Share price movements remained mixed, reflecting differing market reactions to earnings performance, strategic transactions, capital requirements and future growth prospects.

Bumble Shares Surge 56.18% as Ithaca Agrees to $1.3 Billion Acquisition

Bumble Inc. has agreed to be acquired by Ithaca Holdings in an all-cash transaction valued at approximately $1.3 billion, offering shareholders $6.05 per Class A share. The offer represents a 138% premium to Bumble’s unaffected closing price on October 9, 2026, and a 119% premium to its 30-day volume-weighted average price.

The definitive agreement follows a strategic review by an independent board committee, which recommended the proposal after assessing alternatives. The board approved the transaction, and affiliates of Blackstone and Chief Executive Whitney Wolfe Herd provided the required shareholder consent, eliminating the need for an additional shareholder vote.

Following completion, Ithaca co-founders Ravi Gupta and John Hegeman are expected to become co-chief executives alongside Wolfe Herd, who will remain involved. Bumble plans to retain its Austin headquarters and continue operations in London and New York. Ithaca intends to develop the Bumble, Badoo and BFF platforms using technology and operational expertise, including opportunities involving artificial intelligence.

Bumble shares traded at $5.94 on October 13, up 56.18%. The stock opened at $5.98 and recorded an intraday high of $5.98 and a low of $5.93. The market price remained below the agreed $6.05 cash consideration.

Investors will monitor remaining closing conditions and the transaction timetable. Bumble plans to file its third-quarter Form 10-Q by November 9, 2026, but will not hold its usual earnings call.

Alaunos Shares Surge 261.90% as $350 Million Funding Supports Velaris Pipeline Expansion

Alaunos Therapeutics Inc. (NASDAQ: TCRT) announced on October 13, 2026, that it had completed its acquisition of Velaris Therapeutics, expanding into pulmonary arterial hypertension and other cardiopulmonary diseases. Alongside the acquisition, Alaunos raised approximately $350 million through a private placement of Series C non-voting convertible preferred stock led by Fairmount.

Velaris adds biologic drug candidates, including VLR199, VLR360, VLR247 and VLR258, targeting biological pathways involved in pulmonary vascular remodelling. The acquisition broadens Alaunos’s pipeline beyond its existing focus on cancer-related cell and gene therapies.

The financing is intended to support operations through 2029 and fund proof-of-concept studies, pipeline development and regulatory submissions. Other participating investors include Venrock Healthcare Capital Partners, T. Rowe Price Investment Management and Wellington Management. As a clinical-stage biotechnology company, Alaunos continues to rely on financing to advance its development programmes.

Alaunos shares traded at $3.80 on October 13, rising approximately 261.90% from the previous close of $1.05. The stock opened at $1.73, reached an intraday high of $4.32 and touched a low of $1.51. These figures indicate substantial price volatility during the session.

Investors will monitor clinical milestones, regulatory progress and the deployment of the new funding. Despite the acquisition and capital raise, the success of Velaris’s drug candidates remains dependent on clinical trial outcomes and regulatory decisions.

Also Read: What Is the New York Stock Exchange (NYSE)?

JPMorgan Shares Gain 0.62% as Q3 Profit Hits $15.3 Billion Despite Earnings Miss

JPMorgan Chase & Co. reported net income of $15.3 billion for the third quarter of 2026, alongside a 20% return on tangible common equity (ROTCE), highlighting the resilience of its diversified banking operations. However, adjusted earnings per share of $5.75 fell short of analysts’ consensus estimate of $5.93. Managed revenue rose 8% year-on-year to $50.9 billion, supported by growth across consumer banking, investment banking, markets and wealth management.

Net interest income increased 13% year-on-year to $27.1 billion, while noninterest revenue reached $23.8 billion, up 3%. Excluding investment securities losses, noninterest revenue grew 12%. Expenses climbed 12% to $27.3 billion, reflecting higher compensation, technology spending and distribution costs. Credit costs totalled $2.7 billion, including $2.2 billion in net charge-offs and a $539 million net reserve build.

The bank maintained a strong capital position, with a standardized Common Equity Tier 1 ratio of 13.9% and total liquidity resources of $1.5 trillion. Management also indicated that it would prioritise organic growth over share repurchases, citing opportunities to deploy excess capital into the business.

JPMorgan shares were trading at $336.31 during the October 13 session, up 0.62% from the previous close of $334.23. The stock opened at $339.97 and recorded an intraday high of $344.36 and a low of $331.19. The session’s gain came despite the earnings shortfall, although the available data does not establish a direct cause for the share price movement.

Citigroup Shares Fall 3.21% Despite 27% Profit Growth and Q3 Earnings Beat

Citigroup Inc. reported stronger third-quarter 2026 results on October 13, with adjusted earnings per share rising 27% year-on-year to $2.85, exceeding analysts’ expectations of $2.66. Revenue increased 8% to approximately $23.8 billion, slightly above market estimates, while net income reached $5.2 billion. Despite the earnings beat, the bank’s shares declined during Tuesday’s trading session.

Services and wealth management were key contributors, with both businesses recording 15% revenue growth to $6.6 billion and $3.3 billion, respectively. Markets revenue increased 6% to $6.1 billion, supported by a 4% rise in fixed-income revenue to $4.4 billion. Investment banking revenue grew 9% to $1.4 billion, while US personal banking revenue remained flat at $4.7 billion.

Citigroup’s return on equity improved to 10.1%, an increase of 300 basis points, while return on tangible common equity reached 11.5%. The efficiency ratio stood at 58.5%. Average loans rose 12% to $809 billion, and deposits increased 9% to approximately $1.5 trillion. The bank maintained its Common Equity Tier 1 capital ratio at 12.8% and returned about $4.1 billion to shareholders.

Citigroup shares traded at $127.84, down 3.21% from the previous close of approximately $132.08. The stock opened at $131.34, reached an intraday high of $133.50 and touched a low of $127.25. The decline occurred despite better-than-expected earnings, although the available information does not establish a direct reason for the share price movement.

Wells Fargo Shares Fall 1.48% as 13% Profit Growth Fails to Offset Revenue Miss

Wells Fargo & Company reported a 13% year-on-year increase in third-quarter 2026 earnings, with earnings per share reaching $1.87, above analysts’ expectations of $1.84. However, revenue of $21.87 billion fell short of the $22.31 billion forecast, resulting in mixed quarterly results. The bank attributed its performance to loan and deposit growth, stronger fee income in several businesses and disciplined expense management.

Net interest income increased 5% year-on-year, adding $567 million, while average loans and deposits each grew 11%. Wealth and investment management revenue rose 12%, commercial banking increased 6%, and consumer banking and lending gained 5%. Return on tangible common equity reached 16.3%, moving closer to management’s long-term target of 17% to 18%. The efficiency ratio improved to 63% from a year earlier.

Wells Fargo reported a Common Equity Tier 1 capital ratio of 10% and repurchased $2.5 billion in common stock during the quarter. Management projected full-year 2026 net interest income of approximately $50 billion and non-interest expenses of around $55.7 billion. The bank also highlighted investments in artificial intelligence, digital payments and tokenized deposits as longer-term growth initiatives.

Wells Fargo shares traded at $82.10 during Tuesday’s session, down 1.48% from the previous close of $83.32. The stock opened at $80.57, reached an intraday high of $83.43 and touched a low of $80.31. Despite the earnings beat, the revenue shortfall accompanied the decline, although the available information does not establish a direct causal link.

Also Read: How to invest in US stocks

UnitedHealth Raises 2026 EPS Outlook to $20.50 as Shares Gain 1.01%

UnitedHealth Group reported stronger-than-expected third-quarter 2026 results on October 13, beating analysts’ forecasts for both earnings and revenue while raising its full-year profit outlook. Adjusted earnings per share reached $4.69, up from $2.92 a year earlier and above the $4.12 consensus estimate. Revenue totalled $112.7 billion, exceeding expectations of $111.31 billion. The company also raised its full-year adjusted earnings guidance to at least $20.50 per share.

The medical care ratio improved to 88.4% from 89.9% a year earlier, indicating better control over medical costs. Management attributed the progress to improved execution across its UnitedHealthcare insurance and Optum services businesses. The company also highlighted artificial intelligence initiatives, including expanded clinical chart summarisation and faster appeals processing.

UnitedHealth reported $5 billion in share repurchases through the third quarter and $6.2 billion in dividends paid year-to-date. Management identified Medicare Advantage, Medicaid margin recovery and technology-driven efficiencies as key priorities, while maintaining a long-term growth target of 13% to 16%.

UnitedHealth shares were recently quoted at $382.24, up 1.01% from the previous close of $378.52. The stock opened at $397.62, reached an intraday high of $399.88 and fell to a low of $372.80. Although the shares initially rose in premarket trading following the earnings release and improved guidance, the latest session data showed a more modest gain.

Johnson & Johnson Raises 2026 EPS Outlook to $11.10 Despite MedTech Sales Shortfall

Johnson & Johnson reported third-quarter 2026 revenue of $25.4 billion, exceeding analysts’ estimates of $25.28 billion, while adjusted earnings reached $2.59 per share, beating expectations by $0.05. Pharmaceutical sales increased 7.7% to $16.76 billion, supported by strong demand for its autoimmune treatment Tremfya. Sales of the drug rose 68% to $2.4 billion, surpassing analyst expectations of approximately $2.2 billion.

However, the company’s medical technology division recorded sales growth of 2.5% to $8.6 billion, below the $8.71 billion forecast. Management cited pressure from geopolitical tensions in the Middle East, European austerity measures and pricing conditions in China. Johnson & Johnson raised its full-year sales forecast to approximately $101.2 billion at the midpoint and increased its adjusted earnings guidance midpoint to $11.10 per share from $11.04.

The company also reaffirmed plans to separate its DePuy Synthes hips-and-knees business by mid-2027. Chief Financial Officer Joseph Wolk said the proposed spinoff remained the preferred option for creating long-term shareholder value. Reports in September indicated that Apollo Global Management was discussing a potential acquisition of the unit at a valuation approaching $20 billion.

Johnson & Johnson shares traded at $247.83, down approximately 6.05% from the previous close of $263.79. The stock opened at $254.56, reached an intraday high of $256.18 and touched a low of $247.83. The decline came despite the earnings beat and improved guidance, amid concerns over weaker-than-expected MedTech performance.

Johnson & Johnson announced today that its Board of Directors declared a cash dividend of $1.34 per share for the fourth quarter of 2026, according to a press release statement.  The dividend will be paid on December 8, 2026 to shareholders of record at the close of business on November 24, 2026. The ex-dividend date is November 24, 2026.

Goldman Sachs Earnings Jump to $17.01 Per Share as Revenue Beats Forecasts by 10.79%

Goldman Sachs Group Inc. reported stronger-than-expected third-quarter 2026 results, with earnings per share reaching $17.01 against analysts’ estimates of $13.09. Revenue totalled $18.68 billion, exceeding the $16.86 billion forecast and marking the second-highest quarterly revenue in the bank’s history. The performance was supported by record investment banking advisory fees, stronger equities trading and continued growth in asset and wealth management.

Investment banking advisory revenue increased 18% year-on-year to $1.7 billion, while equities revenue surged 72% to $6.4 billion. Assets under supervision reached a record $4.1 trillion, and wealth management client assets climbed to $2.1 trillion. Return on equity stood at 18.7%, while return on tangible equity reached 20.5%.

Management raised its full-year alternative investments fundraising target to approximately $150 billion, up from the previous range of $75 billion to $100 billion. Goldman also increased its quarterly dividend to $5 per share, a 25% rise from a year earlier, and highlighted financing opportunities linked to artificial intelligence infrastructure.

Goldman Sachs shares were quoted at $899.27 during Tuesday’s session, up 0.60% from the previous close of $893.95. The stock’s opening price, intraday high and low were not provided for the relevant US-listed shares. The positive session movement followed the earnings announcement, although the available information does not establish a direct causal relationship.

SSR Mining Shares Fall 7.65% as $464 Million Roxmore Deal Targets Nevada Growth

SSR Mining Inc. has agreed to acquire Roxmore Resources Inc. for approximately $464 million in cash, expanding its Nevada operations through the Converse Gold Project. Roxmore shareholders will receive C$6.75 per share, representing a 27% premium to the October 9 closing price and a 47% premium to its 20-day volume-weighted average price. The transaction’s estimated enterprise value is $392 million, with shareholders also receiving shares in a new exploration company holding certain Roxmore assets.

Located six kilometres from SSR Mining’s Marigold Complex, Converse reported 2.2 million ounces of indicated gold resources and 3 million ounces of inferred resources in its 2026 estimate. SSR Mining expects the project could eventually produce 150,000 to 170,000 ounces of gold annually over an estimated 10-year mine life, with initial production targeted for 2033. Construction capital is estimated at $800 million to $900 million, while more than $200 million in potential undiscounted life-of-mine synergies could arise from operational efficiencies.

The acquisition requires approval from at least two-thirds of votes cast by Roxmore securityholders and court approval. Holders representing approximately 26.8% of Roxmore’s outstanding shares have agreed to support the deal. Funded from existing cash, the transaction is expected to close in the fourth quarter of 2026.

SSR Mining shares traded at $32.73, down 7.65%. The stock opened at $35.51, reached a high of $35.51 and fell to an intraday low of $32.66.

Also Read: US Stock Market Timings 

Fermi Shares Rise 18.62% as AMD Credit Deal Advances Texas AI Infrastructure Project

Fermi Inc. (NASDAQ: FRMI) has signed a credit support agreement with Advanced Micro Devices (NASDAQ: AMD) for a lease covering the first phase of its Project Matador energy and artificial intelligence facility in Carson County, Texas. The agreement supports 222 megawatts of gross power capacity, corresponding to Fermi’s first customer lease announced on August 10, 2026.

The companies also signed a partnership framework agreement exploring future expansion of up to 650 MW of gross power capacity. Fermi said the credit support arrangement represents a milestone toward securing project financing. CEO Lee McIntire described the partnership as establishing a framework for the project’s second and third phases, while AMD highlighted its potential to support large-scale deployment of AI infrastructure.

Fermi reported investing more than $1.5 billion in the development to date. Project Matador is designed to deliver power through a private, behind-the-meter grid. Subject to binding customer agreements, the company expects the campus to eventually scale to approximately 17 gigawatts, using a combination of natural gas, nuclear, utility grid power, solar energy and battery storage. Capital deployment is intended to align with commercial commitments.

Fermi shares traded at $3.84 on October 13, up 18.62%. The stock opened at $3.64, reached an intraday high of $4.06 and touched a low of $3.48. AMD shares traded at $599.04, up 0.78%, after opening at $577.50 and reaching $600.16.

Investors will monitor project financing, binding customer agreements and progress toward planned capacity expansion.

Workday Shares Fall 0.31% as C1.ai Acquisition Targets Enterprise AI Security

Workday Inc. (NASDAQ: WDAY) has signed a definitive agreement to acquire C1.ai, an identity platform designed to manage access permissions for employees and artificial intelligence agents across enterprise systems. The acquisition aims to integrate C1.ai’s identity governance capabilities with Workday’s human resources, finance and IT platform, strengthening security as companies expand their use of autonomous AI agents.

C1.ai connects with business applications, including email, customer relationship management systems, code repositories, financial software and cloud infrastructure. Its technology automates access provisioning and removal as employees join organisations, change roles or leave. Workday expects the integration to extend its Agent System of Record by adding access governance across connected enterprise systems.

Research cited in the announcement indicates that 95% of large US companies operate autonomous agents, while Deloitte research found only 21% report having a mature governance framework for them. The acquisition is intended to address this gap by managing access for both human employees and AI agents.

The transaction is expected to close in the fourth quarter of Workday’s fiscal 2027, ending January 31, 2027, subject to customary closing conditions. Financial terms were not disclosed.

Workday shares traded at $187.66 on October 13, down 0.31% from the previous close of approximately $188.25. The stock opened at $188.98, reached an intraday high of $189.97 and fell to a low of $185.95. Investors will monitor the acquisition’s progress and its potential contribution to Workday’s enterprise AI security offering.

Humana Shares Trade at $428.13 as BlackRock Agrees to $2.8 Billion Clinic Deal

Humana Inc. (NYSE: HUM) has partnered with BlackRock Inc. to manage nearly 150 CenterWell Senior Primary Care clinics, replacing its existing joint ventures with Welsh, Carson, Anderson & Stowe. BlackRock will acquire WCAS’s equity stake, valued at approximately $2.8 billion, while the new joint venture will be majority-owned by BlackRock, with Humana’s CenterWell business retaining a minority interest.

The partnership plans to invest additional capital over the next two years to support clinic operations, open new locations and pursue acquisitions. The arrangement expands BlackRock’s involvement in healthcare infrastructure while allowing Humana to maintain an interest in its senior primary care business.

Humana expects the transaction to reduce balance-sheet liabilities, improve financial flexibility and lower its cost of capital. The deal is expected to close in the fourth quarter of 2026 and is not anticipated to materially affect the company’s 2026 adjusted earnings guidance.

Humana shares traded at $428.13 on October 13. The stock opened at $439.02, reached an intraday high of $442.99 and fell to a low of $410.50. The supplied data does not include the previous closing price, so the exact daily percentage gain or decline cannot be calculated from these figures. BlackRock shares traded at $1,075.44, after opening at $1,088.09 and moving between $1,067.00 and $1,090.68.

Investors will monitor the transaction’s completion and the joint venture’s planned investments in clinic expansion and acquisitions.

SentinelOne Shares Fall 2.61% as Cybersecurity Firm Plans $1.25 Billion Convertible Notes Offering

SentinelOne Inc. (NYSE: S) announced plans on October 13, 2026, to privately offer $1.25 billion in zero-interest convertible senior notes due 2031 to qualified institutional buyers. The company may also allow initial purchasers to acquire an additional $187.5 million in notes under an option exercisable within 13 days of the initial issuance.

SentinelOne intends to use the proceeds to fund privately negotiated capped call transactions, repurchase up to $150 million of its Class A common stock and support general corporate purposes, including working capital, capital expenditure and potential acquisitions. The capped call arrangements are designed to reduce potential shareholder dilution if the notes are converted into shares. Their cap price is expected to represent a premium of at least 100% over the stock’s sale price on the offering’s pricing date.

The notes will be unsecured obligations, and SentinelOne may settle conversions in cash, shares or a combination of both. Final terms, including the conversion rate, will be determined when the offering is priced. Separately, the company plans to establish a $400 million secured revolving credit facility, although discussions with potential lenders are ongoing.

SentinelOne shares traded at $24.86 on October 13, down 2.61% according to the supplied market data. The stock opened at $23.46, reached an intraday high of $25.35 and recorded a low of $23.46. Investors will assess the financing’s potential dilution and its implications for the company’s capital allocation.

Also Read: What Are Fractional Shares? 

Cipher Digital Falls 11.42% on $850M Offering; Select Water Plans $800M Notes; Digi Power X Secures $200M Financing

Cipher Digital Inc. (NASDAQ: CIFR), Select Water Solutions Inc. (NYSE: WTTR) and Digi Power X Inc. (NASDAQ: DGXX) announced separate financing developments on October 13, 2026, covering AI data centre expansion, an acquisition and debt refinancing. Their announcements drew attention to funding requirements, potential shareholder dilution and the execution of planned projects.

Cipher Digital proposed an $850 million convertible senior notes offering alongside an exchange of existing debt securities for common shares, raising concerns about financing costs and potential dilution. Its Black Pearl campus began generating rent in August, while Barber Lake is expected to start generating rental income in October. Cipher shares traded at $11.50, down 11.42%. The stock opened at $11.24, reached an intraday high of $11.70 and touched a low of $10.68.

Select Water Solutions proposed an $800 million senior notes offering maturing in 2034. The proceeds are intended to help finance its acquisition of Pilot Water Solutions, refinance existing debt and cover transaction costs. The acquisition is expected to expand the company’s water management services for oil and gas operations. If the acquisition does not close by March 1, 2027, Select Water Holdings will be required to redeem more than $450 million in notes at the issue price plus interest.

Digi Power X secured a commitment for US$200 million in debt financing to support its 40-megawatt Alabama AI data centre. Syndicated by Goldman Sachs, the financing is expected to close within 90 days, subject to due diligence and other conditions. The company said the funding would help complete the project while preserving corporate liquidity and limiting shareholder dilution. Digi Power X shares traded at approximately $3.055, up 1.16% from the previous close of $3.02. The stock opened at $3.00, reached a high of $3.12 and fell to a low of $2.92. Phase 1 is expected to be completed in December 2026, followed by Phase 2 in March 2027.

P&G Declares $1.0885 Quarterly Dividend After 136 Years of Payments as Shares Trade Near $153

The Procter & Gamble Company (NYSE: PG) declared a quarterly dividend of $1.0885 per common share at its Annual Meeting of Shareholders on October 13, 2026. The dividend is payable on or after November 16 to shareholders of record at the close of business on October 23. The declaration also covers Series A and Series B ESOP Convertible Class A Preferred Stock, whose holders must be recorded at the start of business on October 23.

P&G has paid dividends for 136 consecutive years since its incorporation in 1890 and increased its dividend for 70 consecutive years, underscoring its long-standing shareholder distribution record.

At the annual meeting, shareholders elected all 12 director nominees, with each receiving strong support according to preliminary voting results. They also approved the ratification of the company’s independent registered public accounting firm and an advisory vote on executive compensation. Three shareholder proposals were rejected. Final voting results will be reported in a Form 8-K filing with the US Securities and Exchange Commission after certification.

P&G shares traded around $153.05 during October 13 trading, according to the supplied market quote, compared with a previous close of $153.20, a decline of approximately 0.10%. The stock opened at $154.51, reached an intraday high of $154.75 and fell to a low of $152.22. The company’s quarterly dividend was approximately $1.09 per share, while its indicated dividend yield was around 2.84%.

Overall, October 13 trading reflected mixed reactions to corporate earnings, acquisitions, financing plans and shareholder returns. While UnitedHealth and Goldman Sachs reported strong results, several banking and healthcare stocks declined despite positive earnings. Major acquisition and funding announcements also drove volatility, reinforcing the importance of evaluating financial performance, transaction risks and market movements together.